Under step therapy requirements, patients may be asked to try lower-cost interventions before a GLP-1 medication is approved
How We Support You Beyond the Scale Monthly community seminars Mindset coaching & education Ongoing access to our team for questions and check-ins sustainable transformation supported by a care team that sees the whole you
Future Research Directions Given the expected increase in the prevalence of double diabetes associated with overweight/obesity [61], the use of the highly effective weight loss medications semaglutide and tirzepatide (second-generation incretin analogs) in patients with T1D and LADA may keep on rising in the near future
frozen medication may appear normal but have reduced efficacy
11,227,228 Islet alpha-cell GLP-1R knockout mice were unable to inhibit glucagon secretion at high glucose levels, and surprisingly, these mice exhibited reduced glucagon secretion during low glucose conditions
Reactive astrocytes: production, function, and therapeutic potential
